Reply: Lecanemab: turning point, or status quo? An ethics perspective. Hardy J, Mummery C. Brain 2023;146:e73.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hardy J, Mummery C. Reply: Lecanemab: turning point, or status quo? An ethics perspective. Brain 2023;146:e73.
PMID: 36995943